Showing results (2041-2050 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|January 1, 1993
Recognition of the Qa-2k tumor antigen by T cell receptor gamma/delta of an immunopotentiator-induced tumoricidal T cell of miceT Okazaki, C Nakanishi-Ito, N Seo, et al.Cancer Immunology, Immunotherapy : CII|June 1, 1993
The development and purification of a bispecific antibody for lymphokine-activated killer cell targeting against the rat colon carcinoma CC531P J Kuppen, A M Eggermont, K M Smits, et al.Cancer Immunology, Immunotherapy : CII|June 1, 1995
Activation of human lymphocytes by a monoclonal antibody to B lymphoblastoid cells; molecular mass and distribution of binding proteinB Hardy, M Galli, E Rivlin, et al.Cancer Immunology, Immunotherapy : CII|September 1, 1996
Diabetes mellitus induced by low-dose interleukin-2N Soni, N J Meropol, M Porter, et al.Cancer Immunology, Immunotherapy : CII|November 1, 1996
Gene-modified tumor cells as cellular vaccineS BaskarCancer Immunology, Immunotherapy : CII|November 1, 1996
Active specific immunotherapy with hapten-modified autologous melanoma cell vaccineT SatoCancer Immunology, Immunotherapy : CII|November 1, 1996
Immunogenicity increase of autologous tumor cell vaccines by virus infection and attachment of bispecific antibodiesC Haas, V SchirrmacherCancer Immunology, Immunotherapy : CII|December 1, 1996
Tumor reactivity of immune T cells in short-term cultureJ C Krauss, J M Stein, S ShuCancer Immunology, Immunotherapy : CII|December 1, 1996
Increased microvascular permeability induced by prolonged interleukin-2 administration is attenuated by the oxygen-free-radical scavenger dimethylthioureaM Gutman, R Laufer, A Eisenthal, et al.Cancer Immunology, Immunotherapy : CII|December 1, 1996
Treatment of human lung carcinoma xenografts with a combination of 131I-labelled monoclonal antibody Po66 and doxorubicinB Desrues, F Brichory, H Léna, et al.Pageof 652